您要查找的是不是：
- Clq binding assay 補體第一成分q亞單位結合測定
- Binding assay shown that Vp28 can not binding membrane protein of shrimp gill. 純化的VP28與對蝦鰓細胞膜的結合實(shí)驗表明，VP28不能與對蝦鰓細胞膜結合，即純化的VP28不具有結合活性。
- The dopaminergic receptors were measured with the radio-ligand binding assay. 采用同位素標記法測定受體變化;
- Competitive protein binding assay indicates the level of cAMP is improved when CDCA is given by oral administration. 通過(guò)競爭性蛋白質(zhì)結合分析法測得，鵝去氧膽酸經(jīng)灌胃給藥后能顯著(zhù)提高大白鼠氣管組織中cAMP的含量。
- SSR was detected by radioligand binding assay(RBA) and ER, PR by LsAB method in these groups. 采用RBA法測定各組織的SSR表達 ,采用免疫LsAB法測定ER、PR表達。
- The effects of l-CSL on recombinant D_1R were investigated by [3~H]SCH23390 binding assay and cAMP assay. [~3H]SCH23390受體結合和cAMP測定實(shí)驗檢測左旋氯代斯闊任對重組D_1受體的激動(dòng)作用。
- Method H?3?cAMP was used in protein binding assay to determine the level of cAMP in bovine BTC. 方法運用蛋白競爭結合法用氚（H3）標記的環(huán)磷酸腺苷（adenosine3，5?cyclicmonphos?phate，cAMP）測定牛眼小梁細胞內cAMP的含量。
- Methods: The number and affinity of IR on hepatocyte membrane of ASR were determined with radioligand binding assay. 采用放射配體結合分析方法檢測肝細胞膜胰島素受體的數目與親和力。
- Methods Radioligand binding assay was used to determine the contents of GR and its affinity (Kd). 方法應用胃泌素受體的放射配基結合分析法，測定34例胃癌組織胃泌素受體的含量及其親和力。
- Competitive inhibition assay, saturation binding assay and scatchard analysis testify the expression of LH/hCG receptor. 競爭結合實(shí)驗、受體結合的特異性實(shí)驗、飽和結合實(shí)驗證明3AO細胞上存在特異性的Ll壬七CG受體。
- Methods: Wrap restraint stress induced defecation rats, the guanylin contents in colon and plasma were measured by radioligand binding assay. 方法:建立束縛應激誘發(fā)排便異常大鼠動(dòng)物模型，應用放射配基法測定結腸組織及血漿中鳥(niǎo)苷素含量。
- In PMP radio binding assay of two different 3HPAF concentrations,each specific binding inhibition effect of SY were dosage depenent also. 兩種濃度3HPAF作為配體進(jìn)行PMP受體結合實(shí)驗，不同濃度的紅花總黃色素抑制3HPAF與受體的特異性結合均可見(jiàn)明顯的量效關(guān)系。
- RESULTS In WRP radio binding assay of three different 3HPAF concentrations,each specific binding inhibition effect of SY were dosage dependent. 結果3種濃度3HPAF作為配體進(jìn)行WRP受體結合實(shí)驗，不同濃度的紅花總黃色素抑制3HPAF與受體的特異性結合均可見(jiàn)明顯的量效關(guān)系；
- The binding activity of various CsA analogs was shown as following:CsA>CsC>CsD>CsB.CONCLUSION The cyclophilin A binding assay is sensitive,reproducible and stable. 對幾種CsA類(lèi)似物與CyPA的親和力進(jìn)行測定的結果表明 ,其親和力CsA >CsC >CsD >CsB。
- Our conclusion is that by competitive inhibition assay, saturation binding assay and Scatchard analysis, LH/hCG receptors with high affinity are present on 3AO cells. 結論: 競爭結合實(shí)驗、特異性結合實(shí)驗、飽和結合實(shí)驗表明 3AO細胞膜上存在高親和力的LH/hCG受體。
- The super helix structure of GFM3P1 and GFM3P2 is easily destroyed by 0.2mol/lNaOH, but that of GFM4P2 is hardly destroyed by 2mol/L NaOH in the Congo red binding assay. 經(jīng)剛果紅結合實(shí)驗表明，GFM3P1、GFM3P2的超螺旋結構容易被0.;2mol/L NaOH破壞，而GFM4P2則相反，其超螺旋結構不能被2mol/L NaOH水溶液破壞。
- The adrenoreceptor density of peripheral lymphocyteswere measured by radio ligand binding assay,and the content of interleukin-5(IL-5) and interleukin-12(IL-12) were measured by enzyme-linked immunosorbnent assay. 用放射性配基結合分析法測定外周血淋巴細胞受體的變化,測定血清白介素5(interleukin-5,IL-5)、白介素12(interleukin-12,IL-12)含量。
- Objective To investigate the experiment conditions of albumin cobalt binding assay (ACB assay). And to evaluate the capacity of human albumin to bind cobalt in patients with myocardial ischemia. 目的 探討白蛋白-鈷結合實(shí)驗(Albumin cobalt binding assay, ACB assay)檢測缺血修飾白蛋白(Ischemia modified albumin,IMA)的實(shí)驗條件,初步評價(jià)心肌缺血病人的白蛋白-鈷結合能力。
- A rqdioligand binding assay(RBA)wasdeveloped to detect lymphocyte expression of high andlow affinity membranous interleukin 2 receptor(IL-2R)in 53 patients with obstructive jaudice undergoing biliaarydrainage. 為了解阻塞性黃疸病人的細胞免疫狀態(tài)，我們用放射性配基結合分析法測定53例阻塞性黃疸病人膽道引流前后淋巴細胞膜白細胞介素－2受體（IL－2R）的表達。
- The relative binding affinities (RBA) of four steroid hormonal drugs for estrogen receptors of uterine cytosol were detemined by competitive binding assay and shown to be in the following order: ethinyl ostradiol>estradiol>anordrin>danazol. 根據[~3H]E_2和E_R具有高度專(zhuān)一性及親和力的特性,應用競爭性試驗比較了炔雌醇(EE)、雌二醇(E_2)、雙炔失碳酯(Anordrin)、丹那唑(D)與兔子宮胞液雌激素受體的相對結合親和力;
